相关实验视频
Updated: Aug 15, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.3K
在小鼠中对胺素诱导的肝毒性敏感性取决于PRKDC多态性
Masaki Watanabe1, Momoka Kakutani1, Ryo Ando2
1Laboratory of Laboratory Animal Science and Medicine, School of Veterinary Medicine, Kitasato University, Aomori, Japan.
The Journal of veterinary medical science
|May 28, 2023
概括
阿德里亚米辛 (ADR) 化疗会导致肝损伤,易感性与Prkdc基因有关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 遗传学 是一个遗传学.
背景情况:
- 阿德里亚米 (ADR) 是一种重要的化疗药物,具有显著的毒性.
- 由于ADR引起的肝损伤是一个临床问题,但其机制尚未完全阐明.
- 动物模型显示ADR诱导的脏病与Prkdc基因R2140C多态性有关.
研究的目的:
- 调查Prkdc基因多态性在阿德里亚米辛诱导的肝损伤中的作用.
- 为了比较不同小鼠菌株与不同Prkdc基因型的ADR敏感性.
主要方法:
- 在C57BL/6J (B6J),B6-PrkdcR2140C和BALB/c小鼠中对ADR诱导的肝损伤进行比较研究.
- 评估ADR管理后的肝损伤和损伤标志物.
主要成果:
- C57BL/6J小鼠表现出对ADR诱导的肝损伤的耐药性.
- BALB/c和B6-PrkdcR2140C小鼠表现出对ADR诱导的肝损伤的敏感性增加.
- 在PRKDC基因中的R2140C突变加剧了ADR诱导的肝损伤.
结论:
- 鼠标菌株差异和Prkdc多态性影响对阿德里亚米辛诱导的肝损伤的敏感性.
- Prkdc R2140C突变是ADR诱导的肝脏易感性的一个关键因素.
相关概念视频
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

